This data indicates that somatic mutations, in this case, the JAK2 mutation, can enhance the phagocytic potential of macrophages and likely contributes to the observed reduction of hemoglobin/RBCs in PV mice without CD47-SIRPα interactions (Fig. 1B). The gene discussed is JAK2; the disease is acquired polycythemia vera.